CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
The Role of Weight Loss (WL) as On-Tretament Predictive Factor for SVR in the Treatment of Chronic Hepatitis C (CHC) Patients with Peginterferon alfa–2A (PEG) and Ribavirin (RBV)
DOI 10.1055/s-0031-1295951
Bibliografische Angaben
Nachweis in CareLit
Autor:innenT Witthöft, P Buggisch, D Hüppe, R Heyne, C John, B Möller, G Moog, A Schober, W Schiffelholz, A Baumgarten, G Teuber, T Lutz, A Stoehr, U Alshuth, S Mauss
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe01/2012
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aim: It is helpful to know different baseline and on-treatment factors that help in decision making for intensifying or facilitating therapy. Here we analysed the value of WL during PEG/RBV. Methods: From 2008–2011, 3810 pts were fully documented in a noninterventional study of bng and Roche. Of them 1100 were treated according to consensus guidelines (GT–1/4/5/6 for 48±4 wks, GT–2/3 for 24±2 wks). Pts with HIV or H…
Zitieren
Zitierempfehlung
T Witthöft, P Buggisch, D Hüppe, R Heyne, C John, B Möller, G Moog, A Schober, W Schiffelholz, A Baumgarten, G Teuber, T Lutz, A Stoehr, U Alshuth, S Mauss (2012) The Role of Weight Loss (WL) as On-Tretament Predictive Factor for SVR in the Treatment of Chronic Hepatitis C (CHC) Patients with Peginterferon alfa–2A (PEG) and Ribavirin (RBV). Zeitschrift für Gastroenterologie (01). https://doi.org/10.1055/s-0031-1295951
Mit CareLit weiterarbeiten